MENU

Can Houlihan Lokey (HLI) Stock Reach $180?

a provider of investment banking services

HLI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days
A.I.Advisor
Sep 02, 2026

Can Houlihan Lokey (HLI) Stock Reach $180?

Key Takeaways

  • The selected price target is $180, roughly 35% above Houlihan Lokey's recent trading level near $133.
  • The strongest bullish case rests on record backlog and restructuring momentum, which could re-accelerate revenue once deal closings normalize.
  • The biggest obstacle is the current slowdown in Corporate Finance activity, which drove a recent earnings miss and a sharp pullback from the 52-week high.
  • Key levels to watch include support near $130 and resistance around the $150–$153 zone, where the 200-day moving average sits.
  • Wall Street's consensus target remains well below $180, making the level achievable only under a genuine recovery in M&A activity.

Why Investors Are Watching the $180 Level

Houlihan Lokey, Inc. (NYSE: HLI) is a Los Angeles-based global investment bank specializing in mergers and acquisitions (M&A) advisory, capital markets, financial restructuring, and valuation services. After peaking above $211 in the past year, the stock has retreated to roughly $133, leaving investors to debate whether a recovery toward the psychologically significant $180 mark is realistic.

The $180 figure is not arbitrary. It sits within the upper band of recent analyst price targets, which range from the low $160s to roughly $190, and it represents a round-number milestone that would imply the stock has reclaimed a substantial portion of its losses while remaining below its prior peak. For a stock trading near $133, reaching $180 would require a gain of roughly 35% — a meaningful but not extreme move for a cyclical financial name.

Current Market Position

Houlihan Lokey carries a market capitalization of roughly $9.3 billion and trades at a price-to-earnings (P/E) ratio of about 22. The company pays a quarterly dividend of $0.70 per share, which was recently raised from $0.60, producing a yield near 2%. Its 52-week range spans from about $112.83 to $211.78, underscoring how sharply sentiment has swung in both directions.

The firm operates across three segments: Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA). This structure matters because it creates a degree of countercyclical balance. When M&A slows, restructuring work historically picks up, providing a natural hedge that many pure-play advisory firms lack.

What Could Drive the Next Leg Higher

The clearest catalyst is a rebound in deal activity. In its most recent quarter, management described the Corporate Finance slowdown as a temporary delay rather than structural deterioration, pointing to record backlog, pipeline, and new mandate activity. If those mandates begin converting into closed transactions, revenue and earnings could re-accelerate quickly.

Restructuring remains a genuine bright spot. Management has cited energy-market volatility, private-credit dislocation, and software-sector stress as drivers of elevated restructuring demand. Meanwhile, Financial and Valuation Advisory revenue grew 13% in the latest quarter. The pending acquisition of energy-focused investment bank Intrepid Financial Partners also signals continued strategic expansion into complementary verticals.

What Could Prevent the Move

The most immediate headwind is the very slowdown that pulled the stock down. In the July 2026 quarter, adjusted earnings per share came in at $1.35, well short of the $1.64 consensus, while Corporate Finance revenue fell 24% year over year. Delayed deal closings, geopolitical uncertainty, and weakness in consumer and software valuations disproportionately affected larger-fee transactions.

Until those conditions improve, the market is unlikely to reward the shares with a multiple expansion toward $180. A sustained environment of rising rates, cautious credit markets, or prolonged geopolitical tension could keep M&A volumes depressed for several quarters.

Analyst Opinions and Price Targets

The analyst community offers a mixed but generally constructive view. Consensus price targets cluster between roughly $153 and $166, with a high end near $210 and a low near $145. Recent moves have tilted cautious: several firms trimmed targets — Goldman Sachs to the mid-$160s, Morgan Stanley to $193, and Keefe, Bruyette & Woods to $160 — while maintaining broadly bullish or neutral ratings. US Capital Advisors has set a $187 objective, and Bank of America initiated coverage with a $164 target.

This distribution is instructive for the $180 question. Most mainstream targets sit below $180, meaning the level would require the stock to outpace the consensus view. It is not impossible, but it would demand evidence of a durable deal-making recovery rather than a single strong quarter.

Technical Levels That Matter

From a technical analysis perspective, the stock's path toward a $180 price target runs through several important zones. The recent low near $130.72 has acted as support, and the 52-week low of $112.83 marks a deeper safety net. On the upside, the 50-day moving average has hovered near $140, with the 200-day moving average near $153 serving as a more meaningful resistance level. A sustained move above the $150–$153 band would be an important first step, since it would shift the longer-term trend structure back in favor of buyers before any challenge of $180 becomes credible.

AI Daily Buy/Sell Signals

Traders monitoring Houlihan Lokey or similar financial names can use Tickeron's AI Daily Buy/Sell Signals to stay ahead of shifting conditions. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market behavior, technical patterns, and AI-driven analysis. These signals can help traders discover new opportunities, track existing positions, and identify emerging trends more efficiently than manual screening alone.

Final Assessment

Can Houlihan Lokey reach $180? The path exists, but it is not yet fully supported by current conditions. The bullish case rests on record backlog, a resilient restructuring franchise, and management's characterization of the Corporate Finance slowdown as temporary. If deal closings normalize, a recovery toward $180 is plausible over a longer horizon.

However, the stock currently trades more than 35% below that level, and the consensus analyst target sits meaningfully lower. Until Corporate Finance revenue stabilizes and the shares reclaim their longer-term moving averages, $180 remains an ambitious rather than an imminent objective. Investors should monitor deal-closing activity, restructuring demand, and the stock's ability to hold above $130 while breaking through the $150–$153 resistance zone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
HLI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HLI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLI has been closely correlated with RJF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLI jumps, then RJF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLI
1D Price
Change %
HLI100%
+0.23%
RJF - HLI
76%
Closely correlated
+1.41%
PJT - HLI
70%
Closely correlated
+0.86%
MC - HLI
64%
Loosely correlated
+1.14%
NDAQ - HLI
63%
Loosely correlated
-1.87%
MCO - HLI
60%
Loosely correlated
-0.95%
More

Groups containing HLI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLI
1D Price
Change %
HLI100%
+0.23%
HLI
(4 stocks)
85%
Closely correlated
+2.71%